Azficel-T: Phase II data

A double-blind, U.S. Phase II trial in 21 patients with vocal cord scarring resulting in

Read the full 151 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE